The aim of the study was to determine the expression of tenascin-C and fibronectin in esophageal adenocarcinoma and its precursor stages, and to evaluate if the molecules could be used as prognostic factors or as biomarkers of premalignant lesions. This evidence concerns the gene TNC and esophageal adenocarcinoma.